We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

APP:NASDAQApplovin Corporation Analysis

Data as of 2026-08-31 - not real-time

$308.47

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $308.47, AppLovin Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. Over a rolling month the price has lost 27.4%. With RSI at 35.1 the momentum picture is approaching oversold, alongside a bullish MACD signal. Price has been bracketed by support at $297.50 and resistance at $437.79.
Valuation screens as fair: a P/E of 23.7 sits above the sector average of 16.1. The average analyst target implies 69.3% above today's level. Revenue is growing at 52.8% on a 64.6% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 76.6%, a beta of 2.18 and a maximum drawdown of 59.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Mobile app technology company AppLovin NASDAQ:APP in Q2 CY2026, but sales rose 52.On August 5, 2026, AppLovin Corporation NASDAQ:APP announced its second-quarter results, highlighting revenue that grew...Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 490.89
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 23.7 versus sector average of 16.1
  • Trading below the 200-day average of 490.89

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 23.7 versus sector average of 16.1
  • Analyst targets imply +69.3% versus the current price
  • Profit margin of 64.6% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth52.80%
Profit Margin64.58%
P/E Ratio23.7
ROE203.69%
ROA46.46%
Debt/Equity111.13
P/B Ratio32.7
Op. Cash Flow$4.5B
Free Cash Flow$3.2B
Industry P/E16.1

Technical Analysis

TrendBearish
RSI35.1
Support$297.50
Resistance$437.79
MA 20$325.51
MA 50$405.16
MA 200$490.89
MACDBullish
VolumeDecreasing
Fear & Greed Index94.11

Valuation

Fair Value$330.21
Target Price$522.29
Upside/Downside69.32%
GradeFair
TypeGrowth

Risk Assessment

Beta2.18
Volatility76.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.